Extended Sialylated O-Glycan Repertoire of Human Urinary Glycoproteins Discovered and Characterized Using Electron-Transfer/Higher-Energy Collision Dissociation by Darula, Zsuzsanna et al.
1Extended sialylated O-glycan repertoire of human urinary 
glycoproteins discovered and characterized using EThcD
AUTHOR NAMES
Zsuzsanna Darula1*, Ádám Pap1,2, Katalin F. Medzihradszky1*
CORRESPONDING AUTHORS
Zsuzsanna Darula
e-mail: darula.zsuzsanna@brc.mta.hu
Katalin F. Medzihradszky
e-mail: medzihradszky.katalin@brc.mta.hu
ADDRESS
1Biological Research Centre of the Hungarian Academy of Sciences, Temesvari krt. 62., H-6726 Szeged, 
Hungary
2Doctoral School in Biology, Faculty of Science and Informatics, University of Szeged, Kozep fasor 52., H-
6726 Szeged, Hungary
Page 1 of 48
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
2ABSTRACT
A relatively novel activation technique, EThcD was used in the LC-MS/MS analysis of tryptic glycopeptides 
enriched with wheat germ agglutinin from human urine samples. We focused on the characterization of 
mucin-type O-glycopeptides. EThcD in a single spectrum provided information on both the peptide 
modified and the glycan carried. Unexpectedly, glycan oxonium ions indicated the presence of O-acetyl, and 
even O-diacetyl-sialic acids. B and Y fragment ions revealed that i) in core 1 structures the Gal residue 
featured the O-acetyl-sialic acid, when there was only one in the glycan; ii) several glycopeptides featured 
core 1 glycans with disialic acids, in certain instances O-acetylated; iii) the disialic acid was linked to the 
GalNAc residue whatever was the degree of O-acetylation; iv) core 2 isomers with a single O-acetyl-sialic 
acid were chromatographically resolved. Glycan fragmentation also helped to decipher additional core 2 
oligosaccharides: a LacdiNAc-like structure, glycans carrying sialyl LewisX/A at different stages of O-
acetylation, and blood antigens. A sialo core 3 structure was also identified. We believe this is the first study 
when such structures were characterized from a very complex mixture and were linked not only to a specific 
protein, but also the sites of modifications have been determined.
KEYWORDS
affinity chromatography, blood-type antigen, disialic acid, EThcD, mass spectrometry, O-acetyl-sialic acid, 
O-glycopeptides, urinary glycoproteins, wheat germ agglutinin
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3INTRODUCTION
Protein glycosylation is a common post-translational modification that is responsible for a wide range of 
biochemical interactions. Protein glycosylation can be C-, N-, O- and S-linked and hence a range of amino 
acid side-chains harbor these glycan linkages1. O-glycosylation may alter Ser and Thr side-chains within the 
cytosol as well as within the Golgi1,2. While the intracellular proteins feature a single GlcNAc as 
modification, the Golgi-derived glycans are much more complex, with alternate cores that are usually 
elongated1,2. In mammals the GalNAc-core (mucin-type) glycosylation is the most common1,2. Mucin-type 
O-glycosylation of Tyr residues has also been reported recently3. Early on it has also been observed that the 
same sequence positions may or may not be always glycosylated (macroheterogeneity) and may feature 
several different glycans (microheterogeneity)1. For technical reasons glycoprotein decorating glycans are 
frequently studied after being released4-7. This permits the fractionation and in-depth characterization of 
these oligosaccharides, however, the site-specific information is lost in the process. With the advent of very 
sensitive, high resolution mass spectrometers and new activation techniques, such as ETD (electron transfer 
dissociation8)  and EThcD (electron-transfer/higher-energy collision dissociation9), the focus is shifting 
towards intact glycopeptide or even intact glycoprotein (or at least middle-down) analysis10. While mass 
spectrometry is suitable for identifying most PTM-bearing sequences in an unbiased manner, collision-
induced dissociation (CID), the most commonly used MS/MS activation method for obtaining structural 
information on peptides, performs poorly for O-glycopeptide characterization. The culprit is the glycosidic 
bond that is more prone to fragmentation than the peptide bond and thus, fragment ions resulting from sugar 
cleavages dominate the spectra. The glycan is usually completely released from the peptide, without leaving 
any clue behind on the originally modified amino acid. As a result, little to no information is available to 
assign the glycosylation site(s).10  Hence ion trap CID, i.e. resonance activation only delivers information 
about the glycan size and composition, and the peptide size, while beam-type CID (HCD) may produce 
peptide sequence information, but information on the glycan(s) may be more limited than in ion trap CID 
because of its extensive fragmentation10. Electron transfer dissociation usually results solely in the peptide 
backbone fragmentation, thus, both the modified amino acid sequence and the modification site(s) can be 
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4assigned8. However, ETD spectra frequently yield incomplete sequence ion series, and thus, limited 
information about the glycans present (i.e. it cannot be decided whether the glycopeptide features two small 
glycans or a larger oligosaccharide of the same combined sugar composition) and their location is 
available10. In the newest activation method, EThcD, electron-transfer is performed first, then newly 
generated fragments and intact precursor ions (activated) are subjected to beam-type collisional activation9. 
In this process only some of the ETD-generated fragments undergo further breakdown (such as w ion 
formation11), but the precursor ions are definitely cleaved9. Most of this fragmentation results from 
glycosidic bond cleavages, however, the activation is gentler than in normal HCD and the resulting glycan 
fragments are more abundant, while larger structures also survive12. Thus, we gain information both about 
the peptides modified and the oligosaccharides featured.
In this manuscript we demonstrate that the information content of EThcD spectra enabled the 
characterization of unexpected/unusual sialylated structures on intact glycopeptides that were enriched from 
the urine of healthy individuals. As far as we know this is the first time that such structures have been 
identified from a complex biological matrix, in a high throughput manner, with protein site specificity. The 
presented method opens new possibilities for the discovery of novel glycan structures with site specificity on 
proteins to reveal their biological function and potential as diagnostic biomarkers.
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5EXPERIMENTAL
Here we utilized a glycopeptide enrichment strategy as previously described 12.  We would like to emphasize 
that no acetate buffer or acetic acid containing solution was used in any part of the protocol. Briefly, tryptic 
digests of urine of 4 healthy donors (collected with appropriate consents approved by the Hungarian 
Scientific and Research Ethics Committee (approval number: 1011/16)) were subjected to a 2-round 
glycopeptide enrichment using a wheat germ agglutinin affinity column collecting 2 glycopeptide fractions 
representing the shoulder of the flow through peak and a fraction eluted by GlcNAc. Fractions were 
analyzed separately by LC-MS/MS using a Waters M-Class nanoUPLC on-line coupled to an Orbitrap 
Fusion Lumos mass spectrometer operated in positive ion mode. Peptides loaded onto a trap column (Waters 
Acquity UPLC MClass Symmetry C18 180 μm× 20 mm column, 5-μm particle size, 100-Å pore size; flow 
rate 10 μl/min)  were separated by a linear gradient of 10-30% B in 60 min (Waters Acquity UPLC M-Class 
BEH C18 75 μm× 250 mm column, 1.7-μm particle size, 130-Å pore size; solvent A: 0.1% formic 
acid/water; solvent B: 0.1% formic acid/ACN; flow rate: 300 nl/ min), MS/MS data were acquired using 
HCD product-ion dependent EThcD data acquisition mode. The HexNAc-specific oxonium ion, m/z 
204.0867 among the 20 most abundant HCD fragments triggered EThcD acquisition. HCD spectra were 
acquired at 28% NCE, while supplemental activation in EThcD was set at 15% NCE. Precursors with z=3-5 
were considered (intensity threshold: 106) according to a decision tree with decreasing charge state and 
increasing precursor m/z, in a total cycle time of 3 s. Some samples were also analyzed using direct injection 
(i. e. without trapping) and allowing z=2 precursors.  All measurements were performed in the Orbitrap, 
with a resolution of 60000 and 15000 for MS1 and MS/MS, respectively.
Separate HCD and EThcD peaklists were generated using Proteome Discoverer (Thermo Scientific, 
v2.2.0.388) requiring at least 40 peaks per spectrum. EThcD data were filtered for the presence of m/z 
292.0927 within the top 20 most abundant fragment ions (required mass accuracy: 10 ppm) using the MS-
Filter software of Protein Prospector13 and retained spectra were searched using the Protein Prospector 
search engine with the following settings: enzyme: semitrypsin with maximum 1 missed cleavage site; 
database: human subset of the Swissprot database (2017.9.19.version, 20219 sequences) concatenated with 
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6the same number of random sequences; mass accuracy: 5 ppm for precursor ions, 10 ppm for fragment ions; 
fixed modification: carbamidomethylation (Cys), variable modifications: acetylation (protein N-terminus), 
cyclization (N-terminal Gln), oxidation (Met), and a set of 28 glycan structures representing core 1 and 
core  2 O-glycans with up to 4 sialic acids/glycan (Supporting Information 1, Table S-1) on Ser/Thr. All 
variable modifications were defined as “common” allowing 2 variable modifications per peptide. The 80 
most abundant peaks were considered from each MS/MS spectrum. Glycopeptide identifications were 
accepted applying 5% and 1% FDR on the protein- and peptide-level, respectively, and setting a SLIP-
score14 threshold of 6. All identifications presented were validated manually.
The raw data files have been uploaded to MassIVE 
(https://massive.ucsd.edu/ProteoSAFe/static/massive.jsp), the project’s identifier is MSV000083070.
RESULTS
The workflow
We intend to gain information on the site-specific O-glycosylation of human proteins, and for this purpose 
the analysis of intact glycopeptides from different sources is necessary. In this study tryptic glycopeptides 
were enriched from urine of healthy donors. Previous studies on urinary glycoproteins, applying the sialic 
acid release and capture method15 or the glycoblotting-assisted O-glycomics approach16,17 indicated that core 
2 and disialylated core 1 O-glycans are present at considerable amounts. As glycopeptides bearing these 
structures would not be enriched by lectins frequently used for O-glycopeptide analysis including Jacalin 
and peanut agglutinin, we used wheat germ agglutinin (WGA) that binds a wide array of glycan structures18-
20 including both N- and O-glycopeptides. The glycopeptide mixtures were analyzed applying HCD product 
ion-dependent EThcD with mild supplemental activation (15% NCE), and EThcD data were interpreted 
using Protein Prospector12. As deduced from the number of MS/MS spectra acquired, the two-round lectin 
enrichment was highly efficient: ≥ 94% of the acquired HCD spectra featured the diagnostic glycan 
oxonium ion m/z 204 in all collected WGA fractions12. N- and O-glycopeptides were identified in separate 
searches (for details see 12 and Online Resources 3-4 therein). As the vast majority of the glycopeptides 
represented sialylated glycans12 we used peak lists filtered for the presence of the diagnostic m/z 292. For O-
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7glycopeptide identification a-, mono- and disialo core 1 and the disialo core 2 O-glycan structures were 
considered. Approximately 2/3 of the O-glycosylated sequences reported earlier for urinary proteins15 were 
identified along with several new, mostly multiply glycosylated peptides indicating that WGA affords 
efficient enrichment of O-glycopeptides. However, the overall identification rate was rather low (~5%)12. 
One of the obvious reasons is that in order to keep false discovery rates at acceptable levels, only 2 variable 
modifications per peptide was permitted in these searches. Thus, multiply modified peptides could be 
(mis)assigned only if the combined sugar composition of their glycans equaled to a permitted combination. 
Obviously, glycopeptides with glycans other than the specified structures were also missed. 
Iterative search for unexpected/unusual structures
In order to learn what additional structures occur on the glycopeptides enriched, a non-specified 
modification search18,19 was performed on proteins whose presence was already ascertained: any 
modification up to 3000 Da was allowed on Asn, Ser and Thr residues. From the recurring modification 
masses and manual inspection of some corresponding MS/MS spectra we concluded that structures 
containing disialic acids or O,N-diacetylneuraminic acid(s) also were present and needed to be considered. 
Thus, a more complete glycan database was designed (Table S-1) and a new database search was performed 
with these accurately defined structures as variable modifications. Then the assigned spectra were carefully 
inspected. We observed earlier with O-glycopeptides bearing sialyl core 1 and core 2 structures, that the 
mild supplemental activation during EThcD enables the detection of higher-mass oxonium ions, sometimes 
even the intact glycan12. We hypothesized that such ions together with Y-type fragments (for nomenclature 
see 21) could be used to decipher the glycan structures, for example, the linkage position of the unusual 
disialic acid moiety and the O,N-diacetylneuraminic acids. In addition, our observations could be used to 
establish fragmentation rules for the identification of novel structures.
The final list of unexpected sialic acid-containing glycoforms derived from the above searches is presented 
in Table 1. Table S-2 and Figures S-1-29 contain additional information about the identifications and display 
the supporting MS/MS data. As the focus of this manuscript is to demonstrate how EThcD data can be used 
for glycan structure elucidation, only fragmentation relevant to the glycan structures is detailed below 
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8(although we would like to point out that peptide side-chain w ions were observed in several spectra that 
may aid peptide identification). Here we would like to emphasize that our data does not distinguish the 
isomeric sugar units, resolve position or the stereochemistry of the glycan linkages. These assignments (if 
presented) are based on assumptions and on our general knowledge on mucin-type glycosylation. However, 
as described below, the MS/MS spectra usually provided sufficient information on the direct connection of 
the sugar units or on the branching of the glycans.
Table 1. Glycopeptides carrying O-glycans with O-acetyl- and/or disialic acid(s)1 
Tetra3 Penta3 Hexa3Uniprot 
Acc # Protein Name Peptide
2
1 2 0 1 2 3 1 2
Q9GZM5 Protein YIPF3 342AVAVTLQSH350 + + + + + + + +
P01344 Insulin-like growth factor II
93DVSTPPTVLPDNFPR107 + +
175AQDGGPVGTELF186 +
175AQDGGPVGTELFR187 +
247VWGQGQSPRPE257 +
247VWGQGQSPRPENSLER262 + +
P78423 Fractalkine
263EEMGPVPAHTDAF275 + +
Q9BZL3
Small integral 
membrane protein 
3
1MDAVSQVPMEVVLPK15 + +
33SLPEDIETVTASQMR47 +
P98160
Basement 
membrane-specific 
heparan sulfate 
proteoglycan core 
protein
48WTHSYL53 +
Q13508
Ecto-ADP-
ribosyltransferase 
3
316ILEPTQIPGMK326 +
Q9H2B2 Synaptotagmin-4 9EEFDEIPTVVGIF21 +
Q8TBP5 Membrane protein FAM174A
50PRTLPPLPPGPTPAQQPGR68 +
P09603
Macrophage 
colony-stimulating 
factor 1
370VGPVRPTGQDWNHTPQK386 +
P14209 CD99 antigen 29SDALPDNENKKPTAIPK45 +
P60022 Beta-defensin 1 22GNFLTGLGHR31 +
1 identified by Protein Prospector and validated manually. 
2 Ser/Thr residues printed in red denote the site of glycosylation.
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93Tetra, penta and hexa stands for the total number of the monosaccharides within the glycan structure. 
Numbers in the next row specify the number of NeuAcAc residues in the glycan. Proposed structures are 
shown in Table S-1, and in Figures S1-29.
EThcD fragmentation ‘rules’ at low normalized collision energy
As a general observation, gentle supplemental energy (NCE: 15%) applied in EThcD typically seemed to 
favor single bond cleavages. Glycan fragmentation yielded non-reducing end B ions, frequently even larger 
(up to 6 residues) oligosaccharides were detected12, and less prominent internal fragments could be observed 
compared to HCD (acquired with NCE: 28%) (Figures S-1-29 display the corresponding HCD and EThcD 
spectra for each assigned glycopeptide, in certain instances we highlighted the fragmentation differences). 
These ions together with reducing end Y fragments usually provided insight into the glycan structure as 
detailed below.
O-acetyl-sialic acid-containing glycans
Fragments at m/z 334.113 and 316.103 indicated the presence of 9-O-acetyl,N-acetylneuraminic acid 
(Neu5,9Ac2 according to convention, but defined as NeuAcAc in the database searches) within some glycan 
structures (m/z 316 represents water-loss from Neu5,9Ac2). Obviously, from these data it cannot be 
determined which position was acetylated, however, this structure is the most likely1. Screening for these 
fragments with MS-Filter of Protein Prospector13 showed that ~5% of all EThcD spectra featured at least 
one of these oxonium ions. Database searches allowing Neu5,9Ac2 (NeuAcAc) containing glycans yielded 
confident identifications (Table 1, Table S-2, Figures S-1-29). 
Neu5,9Ac2 was always found in terminal position as evidenced by the Y ions formed via Neu5,9Ac2-loss 
from the charge-reduced precursors. Confidently assigned glycopeptides featured tetra-, penta- and 
hexasaccharides with up to three Neu5,9Ac2 residues/glycan (Table 1). However, manual evaluation altered 
the assignment that indicated the presence of an ‘internal’ Neu5,9Ac2 (see below).
In the core 1 tetrasaccharides containing one Neu5,9Ac2, this sugar was Gal-linked as evidenced by the B2 
ion representing GalNeu5,9Ac2 (at m/z 496.166) and the corresponding Y1,α ion, at m/z 710.345(2+) (Figure 
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10
1). This B2 ion in EThcD is usually of higher abundance than the GalNAcNeuAc internal fragment (at m/z 
495.182) that is more prominent in HCD (see Figure S-1). Actually, the GalNeu5,9Ac2 B2 ion may be 
overlooked in HCD as the isotopic peak of the internal fragment. The ion at m/z 990.34 represents the intact 
oligosaccharide.
30
25
20
15
10
5
0
10
4  I
nt
en
si
ty
18001600140012001000
m/z
1.0
0.8
0.6
0.4
0.2
0.0
10
6  I
nt
en
si
ty
800600400200
m/z
22
8.
09
7
25
9.
17
6
27
4.
09
1
31
6.
10
2
33
4.
11
2
29
7.
11
9
35
8.
24
4
42
5.
17
7
46
3.
25
8(
2+
)
46
8.
23
2
49
5.
18
1
49
6.
16
4
56
4.
79
8(
2+
)
71
0.
34
5(
2+
)
69
9.
24
8
79
1.
37
1(
2+
)
81
2.
37
6(
2+
)
93
6.
92
0(
2+
)
95
7.
92
8(
2+
)
99
0.
33
6
z*2 c3
w3
Ac
c4
w4
Y0
z4
Ac Y1
Ac
Y1
Y2
Y1
pr pr
-Ac
Ac
11
28
.5
86
Y1 12
77
.6
10
*
14
48
.6
22
c5
14
85
.7
09
15
61
.7
05
15
81
.7
35 16
23
.7
46
16
57
.6
79
16
89
.7
64
c7
z6
Y1c6
Y2
17
76
.8
03
17
29
.7
22
z*7
c8
1916.859
pr
18
28
.8
02
z*8
14
19
.6
79
Y1 18
73
.8
37
18
99
.8
38
15
58
.6
10
z5
12
81
.6
49
c8 c8
355.147
z3
Figure 1. EThcD spectrum of m/z 638.954(3+), identified as 
342AVAVT(HexNAcHexNeuAcNeuAcAc)LQSH350 of Protein YIPF3. The Gal of the mucin-type core 1 
structure is capped with a Neu5,9Ac2 moiety. (This sugar is listed as NeuAcAc in the glycan library for 
database searches). Oxonium and related ions are labeled according to the CFG recommendations, for the 
reducing end fragments – printed in red - the Domon-Costello nomenclature is followed21. The sialic acid 
loss from the core GalNAc yields the Y1β fragment. z+1 peptide ions are distinguished with asterisks. 
Peptide fragments in blue indicate that some glycan fragmentation occurred in EThcD, the loss of the 
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11
NeuAc and GalNeu5,9Ac2 from the c8 fragment, respectively. The asterisk-labeled ion is the charge-reduced 
form of a doubly charged coeluting molecule.
In a disialo core 2 hexasaccharide with one Neu5,9Ac2, this capping residue can be linked to either of the 
galactoses. Protein Prospector delivered the same identification for EThcD data acquired at different time 
points from precursor ion m/z 760.664(3+), as 342AVAVT(HexNAc2Hex2NeuAcNeuAcAc)LQSH250 of 
Protein YIPF3 (Q9GZM5) (Figures S-7 & S-8). Both spectra display the intact glycan fragment (at m/z 
1355.46) to confirm the presence of a hexasaccharide as opposed to two smaller structures, and Neu5,9Ac2 
is Gal-linked (see m/z 496.166). However, as Figure 2 shows in detail, two isomeric glycoforms were 
present in this sample. In the earlier eluting, more abundant glycoform, the Neu5,9Ac2 is capping the 
GlcNAc-Gal arm (designated as ‘β-chain’, Figure 2, lower panel). This arm can readily be removed by a 
single cleavage yielding an oxonium ion of HexNAcHexNeuAcAc composition at m/z 699.245 (B3β), and 
the corresponding Y1β fragment at m/z 791.372(2+). These ions are missing from the other isoform, where 
the Neu5,9Ac2 is capping the core GalNAc-linked Gal (designated as ‘α-chain’, Figure 2, upper panel). 
Thus, when the bond between the core GalNAc and its modifying GlcNAc is cleaved, an abundant B3β can 
be observed at m/z 657.234, and the corresponding Y1β was recorded at m/z 812.378(2+). The other 
fragments are of identical composition, but they are the products of different bond cleavages as indicated in 
their assignments. In addition, the relative intensities of Y1α and Y2β are different, it seems that the cleavage 
between the core GalNAc and Gal is preferred to that between the GlcNAc and the Gal linked to it. Here 
again, we would like to point out that the internal fragmentation of the glycan is less extensive than in HCD: 
m/z 366.139 representing HexNAcHex is more abundant in the HCD spectra, and the HexNAc2 fragment 
(m/z 407.166) was not detected in EThcD (See Figures S 7-9).
Page 11 of 48
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
12
60
50
40
30
20
10
0
10
4  I
nt
en
si
ty
1000900800700600
m/z
1.2
1.0
0.8
0.6
0.4
0.2
0.0
10
6  I
nt
en
si
ty
1000900800700600
m/z
65
7.
23
1
65
7.
23
4
69
9.
24
5
pr
pr
79
1.
37
2(
2+
)
74
7.
36
6(
2+
)
64
5.
82
8(
2+
)
66
6.
33
9(
2+
)
81
2.
38
0(
2+
)
82
8.
39
2(
2+
)
89
2.
91
8(
2+
)
91
3.
91
6(
2+
)
97
3.
93
9(
2+
)
99
4.
94
3(
2+
)
92
5.
50
8
74
7.
36
3(
2+
)
81
2.
37
8(
2+
)
82
8.
39
1(
2+
) 97
3.
93
9(
2+
)
99
4.
94
3(
2+
)
89
2.
91
2(
2+
)
92
5.
51
2
91
3.
92
1(
2+
)
Y1
Y1
B3
B3
Ac
Ac
Y2
Y2
Y1
Y2
Y1
Y2
Y0
Y0
Y2Y3
Y2
Y3
Y1
Y1
Y2
Y2
Figure 2. Part of the EThcD spectra acquired from m/z 760.664(3+) at RT=14.95min (Lower panel) and at 
RT=18.29min (Upper panel). Both spectra were assigned as 
342AVAVT(HexNAc2Hex2NeuAcNeuAcAc)LQSH350 of Protein YIPF3 (for full spectra see Figures S-7 & 
S-8). (NeuAcAc stands for Neu5,9Ac2 in the glycan library for database searches.) However, the glycan 
fragments revealed isomeric glycoforms. The diagnostic fragment ions and the underlying cleavages are 
indicated in matching colors.
Finally, an identification indicated the presence of a pentasaccharide structure with three NeuAcAc residues 
(Figure 3). Although the additive mass of the glycan (1364.45 Da) is correct, we found this identification 
highly unlikely as it suggests the presence of a non-terminal Neu5,9Ac2 considering the structure of the 
pentasaccharide glycans (see below). Careful investigation of the EThcD spectra revealed that three different 
sialic acids modified the core 1 glycan: the Gal is capped with a Neu5,9Ac2, while the GalNAc is linked 
directly to a NeuAc that is further elongated with a sialic acid bearing 2 ‘extra’ acetyl groups. This is likely 
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an O-4,9-diacetyl-N-acetylneuraminic acid1. The presence of such a neuraminic acid derivative, perhaps 
Neu4,5,9Ac3, was confirmed by its proper oxonium ion and the corresponding water-loss fragment  at m/z 
376.124 and 358.112, respectively (both within 4 ppm of the theoretical m/z values). The GalNeu5,9Ac2 
linkage was validated by Y1α representing the loss of the hexose along with the terminal sialic acid, at m/z 
897.899(2+). The GalNAc-linked NeuAcNeu4,5,9Ac3 structure is supported by the observation of the above 
described Y1α fragment, and by the consecutive losses of Neu4,5,9Ac3 and NeuAcNeu4,5,9Ac3 at m/z 
957.924(2+) and 1623.747, respectively.
Figure 3. EThcD spectrum of m/z 763.992(3+) manually assigned as 342AVAVTLQSH350, modified at Thr-
346 with a core 1 glycan that features a Neu5,9Ac2 on the Gal residue, and a NeuAc-Neu4,5,9Ac3 disialo-
unit on the core GalNAc. ‘Pr’ indicates the different forms of the precursor ion. z+1 peptide fragments are 
distinguished with asterisks. The oxonium ions identifying the three different sialic acids are labeled with 
the CFG symbols, for the reducing end fragments – printed in red - the Domon-Costello nomenclature is 
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followed21. The GalNAc modifications were considered the β-arm. The asterisk-labeled ion is the charge-
reduced form of a doubly charged coeluting molecule.
Scheme 1. Fragmentation of the glycan structure assigned from the spectrum in Figure 3.
Disialic acid-containing glycans
Obviously, there is an overlap between the unusual glycopeptides featuring O-acetyl-sialic acids and the 
ones bearing core 1 structures  modified with a disialic acid unit (Table 1). The terminal residue of this 
disialic unit may be NeuAc or may bear additional O-acetyl groups, i.e. it may be Neu5,9Ac2 or 
Neu4,5,9Ac3 (as described above). The disialic acid unit usually produces a relatively abundant oxonium ion 
at m/z 583.197 or 625.210 for (NeuAc)2 or NeuAcNeu5,9Ac2, respectively. Filtering for the presence of 
these ions with MS-Filter13 showed that ~2% of all EThcD spectra represented glycopeptides with disialic 
acid within the glycan structure. The composition of the modifying glycan was frequently confirmed by an 
oxonium ion representing the intact glycan, at m/z 1239.43 or 1281.44.
EThcD fragmentation of a glycopeptide with a pentasaccharide glycan is illustrated in Figure 4. The glycan 
carries three “simple” NeuAc units, Y ions representing neutral losses of (NeuAc)2 at m/z 1156.04(2+), and 
HexNeuAc at m/z 1220.56(2+) prove that the glycan is branched, and the disialic acid is linked to the core 
GalNAc. The inter-sialic acid bond is confirmed by the (NeuAc)2 oxonium ion (B2β) at m/z 583.197. The 
oxonium ion representing the intact glycan at m/z 1239.41 confirms that a single glycan modifies the 
peptide. In a similar fashion we could decipher that (whenever there was conclusive evidence) the disialic 
acid was always GalNAc-linked. Limited internal fragmentation of the glycan was observed for this class of 
glycopeptides as well. While in HCD the internal fragment representing GalNAcNeuAc (m/z 495.182) was 
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usually abundant, in EThcD the B2 ion representing GalNeuAc (m/z 454.155) was dominant (for example, 
see Figures S-10-12).
Figure 4. EThcD spectrum of m/z 965.092(3+), identified as 
93DVSTPPT(HexNAcHexNeuAc3)VLPDNFPR107 of Insulin-like growth factor II. The precursor ion and its 
charge-reduced form are labeled with ‘pr’. The nonreducing end fragments are labeled with cartoons 
according to the CFG recommendations, the reducing end fragments, printed in red, follow the 
nomenclature21. The inset shows the intact glycan and its oxonium ion is labeled by a red asterisk. The other 
asterisk-labeled ion is the charge-reduced form of a doubly charged coeluting molecule. For full peaklist see 
Figure S-10.
Interestingly, if only one Neu5,9Ac2 was present in the glycan structure, it was always Gal-linked in the 
tetrasaccharides, while in pentasaccharides the GalNAc-linked disialic acid was terminated with it.
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Additional unusual glycans
Finally, the database search permitting unspecified modifications delivered two intriguing suggestions. First, 
it identified a glycopeptide with a glycan mass of 1062.39 Da (Figure 5). This mass corresponds to a 
HexNAc3HexNeuAc glycan composition, that is most unusual for an O-glycan (the calculated mass is 
1062.386, within 2 ppm). The observed non-reducing end B and reducing end Y carbohydrate fragments 
suggest that this unusual glycan might be a Galβ3(GalNAcβ4GlcNAcβ6)GalNAc, the LacdiNAc-like 
structure described by Jin at al.22, from a human gastric mucin sample. We detected  this structure modified 
with a sialic acid on the galactose (Figure 5, Scheme 2). More specifically, the fragment ion at m/z 407.165 
confirms the inter-HexNAc linkage and also indicates that this is a terminal HexNAc-HexNAc structure. 
Although m/z 407 can, in principle, also be formed as an internal fragment of core 2 glycans, it was not 
detected in their respective EThcD spectra (see Figures S-7-9). Similarly, m/z 454.154 indicates a terminal 
HexNeuAc group. These ions together with reducing end Y ions unambiguously show that the glycan is 
branched and a HexNeuAc and a HexNAc2 are linked to the core GalNAc. The B3 fragment representing the 
intact glycan was detected at m/z 1063.398.
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Figure 5. EThcD spectrum of m/z 627.634(3+). The database search permitting unspecified modifications 
identified as 45VATT(1062.388)VISK52 of Plasma protease C1 inhibitor. z* indicates a z+1 peptide 
fragment. The intact glycan oxonium ion confirms that the peptide is modified by a single oligosaccharide of 
HexNAc3HexNeuAc composition. The glycan fragments helped to decipher the branching and linkages 
within the oligosaccharide, a core 2 based LacdiNAc-like structure22. Scheme 2 illustrates which bonds are 
cleaved. z* indicates a z+1 peptide fragment. The asterisk-labeled ion is the charge-reduced form of a 
doubly charged coeluting molecule.
Scheme 2. Fragmentation of the glycan structure assigned from the spectrum in Figure 5.
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The second fascinating identification was 345SLTVS(1370.497)LGPVSKT(HexNAcHexNeuAc)EGFPK361 
from Protein HEG homolog 1 (Q9ULI3), where the modification mass, suggested by the search engine, 
corresponded to a HexNAc3Hex2FucNeuAc composition, that could represent a core 2 structure bearing an 
A-type antigen (see later). However, an abundant oxonium ion at m/z 674.252 (HexNAcHex2Fuc) and the 
similarly abundant corresponding Y fragment, at m/z 1034.16 (3+) strongly suggested the presence of a core 
2 glycan carrying a blood-type B antigen. The assigned modifications and the fragments observed 
contradicted each other. Our investigation revealed that a series of unassigned doubly charged fragment ions 
could be identified as z ions (z7-z12) from the mass differences between them. These fragments’ mass shift 
(697 Da) clearly indicated that the Thr carries a HexNAc2NeuAc oligosaccharide, most likely a sialylated 
core 3 structure , i.e. a GlcNAc3(NeuAc)GalNAc instead of the core 1 trisaccharide. The oxonium ion 
of this glycan was subsequently identified at m/z 698.266. Thus, the ‘leftover’ glycan on Ser-349 features a 
HexNAc2Hex3FucNeuAc composition that is indeed a core 2 structure decorated with the B blood-type 
antigen (Figure 6, Scheme 3). The donor’s blood type was AB.
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Figure 6. EThcD spectrum of m/z 944.178 (4+) manually assigned as 345SLTVS*LGPVSKT*EGFPK361 
from Protein HEG homolog 1 (Q9ULI3), with a core 2 structure carrying a B-antigen on Ser-349 and a 
sialyl core 3, GlcNAc3(NeuAc)GalNAc on Thr-356. The intact sugar oxonium of this glycan was  
detected at m/z 698.266. Its modification site was determined from the series of doubly charged z7-z12 
fragments. Scheme 3 illustrates bond cleavages within the larger glycan structure.The precursor ion and its 
charge-reduced form are labeled with ‘pr’; the charge-reduced form of a coeluting doubly charged 
component is indicated with an asterisk.  Y ions reflect the fragmentation of the core 2 glycan carrying the B 
antigen.
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Scheme 3. Fragmentation of the mucin core 2 glycan carrying blood-type antigen B structure assigned from 
the spectrum in Figure 6.
Targeted glycoform identification for a specific peptide
These unusual structures prompted us to further investigate the presence of additional glycoforms for the 
peptide that already featured the highest microheterogeneity: 342AVAVTLQSH250 of Protein YIPF3. Using 
the MS-filter option of Protein Prospector13 with one of the datafiles representing the earlier eluting 
glycopeptides, we identified all HCD spectra that displayed the gas-phase deglycosylated Y0 fragment (m/z 
925.510) among the 5 most abundant ions and with a mass measurement error below 10 ppm. Then the 
potential glycan masses were calculated for each such component and 4 new glycan structures emerged with 
compositions of HexNAc3Hex2FucNeuAc, HexNAc2Hex2FucNeuAc2, HexNAc2Hex2FucNeuAcNeuAcAc 
and HexNAc2Hex2Fuc(NeuAcAc)2, represented by incremental monoisotopic masses of 1370.499, 
1458.514, 1500.516 and 1542.537 Da, respectively (Table S-3). Placing these numbers as modifications 
within the sequence, and comparing the MS-product predictions (Protein Prospector) with the EThcD data it 
became clear that Thr-346 was always the glycosylation site.
The first structure is most likely, a core-2 glycan carrying the A blood antigen as shown in Figure 7, Scheme 
4. While the identity of the sugar units and their linkage positions obviously could not be determined from 
these data, the connections between the units could be deciphered from the EThcD spectrum (Figure 7). An 
oxonium ion at m/z 512.202 and the corresponding Y fragment indicated a terminal HexNAcHexFuc 
structure. Other reducing end fragments identified a hexose-linked sialic acid as well as a terminal HexNAc. 
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Since single bond cleavages are preferred in EThcD, the presence of an abundant B-fragment at m/z 657.237 
and its reducing end counterpart at m/z 820.399(2+) suggest that the core GalNAc is modified with a 
HexNAcHexNeuAc structure and the other extension might be the A-antigen because of its composition and 
terminal HexNAc. These conclusions were further strengthened by the Y2β,1α fragment detected in HCD at 
m/z 1437.715 (Figure S-30). This A-antigen featuring peptide was identified from the same donor as the B-
antigen carrying molecule described above.
The other sugar compositions suggest the presence of Sialyl LewisX/A in different stages of O-acetylation 
(See Table S-3; Figures S-31-34). The isomeric structures containing one O-acetyl-sialic acid were 
chromatographically resolved, and the earlier eluting isoform carried this modification on the GlcNAc-
containing arm, just like in the hexasaccharide isomers presented in Figure 2. Interestingly, all fucose-
containing glycoforms produced a few ions that indicated fucose transfer between the extensions (Figures 6-
7, Figures S-31-35). Fucose ‘migration’ has been reported in glycan analyses23 as well as for N-linked 
glycopeptides24,25.
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Figure 7. EThcD spectrum of m/z 766.008(3+) that was manually assigned as 342AVAVTLQSH350 of 
Protein YIPF3 bearing a HexNAc3Hex2FucNeuAc glycan on Thr-346. The precursor ion and its charge-
reduced form are labeled with ‘pr’; the charge-reduced form of a coeluting doubly charged component is 
indicated with an asterisk. The glycan was assigned as a core 2 glycan featuring the A antigen linked to the 
GalNAc. A similar core 2 A antigen has been described on gastric mucin by Rossez et al.26 Scheme 4 
illustrates which bonds are cleaved. m/z values printed in bold label fragments that indicate fucose transfer 
between the antennae: m/z 803.298 represents a HexNAcHexFucNeuAc structure, while m/z 965.931(2+) 
was formed via HexNAcHex loss from the precursor ion.
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Scheme 4. Fragmentation of the glycan structure assigned from the spectrum in Figure 7.
In a similar attempt as described above, an additional glycoform of this peptide bearing a more extended 
sugar structure (HexNAc3Hex3FucNeuAc2, mass increment: 1823.65 Da),  representing an extended core 2 
glycan decorated with Sialyl LewisX/A was identified in a later eluting glycopeptide fraction (Figure S-35, 
Table S-3).
DISCUSSION
In order to understand the biological role(s) of O-glycosylation addressing the site-specificity of the 
modifications is necessary. However, the enrichment and characterization of O-glycopeptides is an even 
more daunting task than deciphering N-glycosylation10.
One tends to believe that mucin-type O-glycosylation operates with only a handful of structures. For 
example, serum proteins feature primarily mono- and disialo core 1 glycans27. However, the glycan 
repertoire is much more diverse for gastric mucins22,26, and as presented here the urinary glycoproteome is 
much more complex as well. Our results also indicate that removing the sialic acids indeed may make the 
investigated mixtures simpler, but at a significant price i.e. losing valuable information on 
microheterogeneity. Peptides featuring multiple potential glycosylation sites may display an overwhelming 
degree of macro- and microheterogeneity. For example, the complexity generated by macroheterogeneity 
could be illustrated by the glycoforms reported for the 154Ser-Lys175 region of bovine insulin-like growth 
factor II28 , while for microheterogeneity we have just presented the 342Ala-His350 stretch of Protein YIPF3 
(its ‘normal’ disialo core 1, and core 2 glycoforms were described in our earlier report12). Obviously, this 
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heterogeneity makes the chromatographic separation of the different glycoforms harder, and may also 
prevent the detection of minor components. Differentiation between the isomeric structures as well as 
positional isomers presents an even greater challenge. 
As briefly summarized in the introduction, the different MS/MS activation techniques deliver different clues 
to solve the glycopeptide puzzle. Unfortunately, these data are rarely used in concert, and primarily via 
manual data interpretation. Perhaps eventually a software tool will be developed that can utilize orthogonal 
data sources, but until then EThcD, yielding both glycan and peptide fragments is the best approach for 
identification. For example, abundant oxonium ions indicate the presence of the different neuraminic acids. 
The diagnostic value of such Neu5,9Ac2 fragments has been reported for beam-type CID data13, here similar 
ions revealed the presence of a Neu4,5,9Ac3 moiety. Oxonium ions of sialic acids are very abundant in the 
EThcD spectra12, and in complex mixtures numerous spectra may display them due to precursor ion 
interference. Thus, they have to be considered with caution as unambiguous evidence for sialylation. 
However, the lack of these diagnostic oxonium ions clearly signals that no glycan featuring the 
corresponding sialic acid might be present.  Thus, screening the peaklists for such diagnostic fragments 
could be recommended prior to database searches, or PSMs assigned to sialic acid-containing structures 
should be considered false whenever the diagnostic oxonium ions were not observed.
In an earlier publication beam-type CID (HCD) spectra of murine nucleobindin-1 glycopeptides  illustrated 
that internal glycan fragments representing the core GalNAc modified with N-acetyl, N-glycolyl, or N,O-
diacetylneuraminic acid helped assign the different versions of the disialo-core 1 tetrasaccharides13.  The 
HCD data acquired in this study (Figures S-1-35) are in good agreement with these observations.  However, 
while the internal oxonium ion is the dominant species in HCD, the terminal B2 fragment produced by a 
single bond cleavage is significantly more abundant in the EThcD spectra. With the mild EThcD activation 
the products of single bond cleavages are detected preferentially, even if internal fragments may be 
observed.  As described, the glycan fragments help to determine the direct linkages between the sugar units. 
In fact, the occurrence of B2 ions representing disialic acids is so high that they might be used as reporter 
ions for the presence of these disaccharide units, and can be used for prefiltering the peaklists when 
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searching for glycopeptides bearing such glycans. While most such glycoforms will be identified in general 
database searches as well, the FDR rate is higher, and thus, lower scoring true identifications may ‘sink’ into 
the background12.  Obviously, these fragments also should be considered as strong evidence in glycopeptide 
fragmentation scoring.  Glycan fragmentation in EThcD also may permit the correct assignment of isomeric 
structures as presented in this manuscript. It would be beneficial if these observations were incorporated into 
the automated evaluation of glycopeptide EThcD spectra. The gentler activation also enables, not 
infrequently, the survival of the oxonium ions representing even penta- or hexasaccharides. The presence of 
these fragments can help to differentiate between the different glycans or glycan combinations that represent 
identical mass additions. As these fragment ions are often rather weak, it is not very likely that precursor ion 
interference could ‘inject’ them into the spectra. Considering them as positive evidence for the presence of 
larger glycans is recommended.
Manual investigation of the spectra also drew our attention to a peak picking issue. Here we do not refer to 
the misidentification of the monoisotopic mass in the precursor ion cluster – although this is still a persistent 
problem. When evaluating the raw spectra there were often additional peaks that could provide glycan 
structural or site localization information but were not considered by the search engine.  Some of these were 
due to incorrect determination of a fragment monoisotopic peak or removal of a peak during deisotoping, 
and others were removed by an intensity-based filter. This is likely a result of search engines being 
optimized for peptide identification; as adding in lower intensity peaks, several of which are background 
ions, can reduce statistical significance of the peptide assignment.
As for the biological significance of our findings, presently we cannot offer any convincing hypothesis. 
Polysialic acid has been found both in N- and O-glycans, and depending on the degree of polymerization can 
be categorized as di-, oligo- and polysialic acids29. The presence of such structures is usually determined 
using immunochemistry. While polysialylation clearly has a role in neural development30, it has also been 
implied in cancer metastasis31. On the other hand, although disialic acid units have been detected on multiple 
glycoproteins32-36, no clear biological role has been linked to this structure yet. The proteins identified in the 
present report also participate in diverse biological processes including cell adhesion (Macrophage colony-
Page 25 of 48
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
26
stimulating factor 1, fractalkine, CD 99), glucose metabolism (insulin like growth factor II) or maintaining 
the structure of the cell membrane (basement membrane-specific heparan sulfate proteoglycan core protein) 
or the Golgi (YIPF3). 
Nonetheless, the sialyltransferases catalyzing the formation of disialic acids are known. ST8Sia VI is 
responsible for disialic acid formation in O-glycans catalyzing the formation of both 
NeuAc2,8NeuAc2,3Gal and NeuAc2,8NeuAc2,6GalNAc structures37,38 with higher preference 
towards the NeuAc2,6GalNAc substrate. Our findings are in good agreement with the above observation, 
disialic acid was linked to the core GalNAc in the glycopeptides characterized.  In addition, ST8Sia VI is 
expressed at higher levels in kidney37, thus, perhaps urinary proteins may feature more of these structures. 
As far as we know this is the only report where site-specific information was obtained on multiple proteins 
for the disialic acid carrying O-glycopeptides. The only other study describing a similar pentasaccharide 
structure was reporting on amyloid peptides isolated from human cerebrospinal fluid. However, in that case 
the pentasaccharide modified a Tyr residue, and MS/MS data indicated that the disialic acid unit was linked 
to the galactose3.
O-acetylation of sialic acid plays a role in cell-cell interactions and non-immune protection of mucosa39. It 
was suggested that O-acetylation of neuraminic acids on cell surfaces “may protect against pathogen 
infection by preventing degradation of membrane-associated mucins”40. At the same time another report 
links the expression of O-acetyl sialoglycoproteins on erythrocytes to leukemia41. None of these studies 
characterized the O-acetylneuraminic acid-containing glycan structures, or pinpointed their location within 
any particular protein or residue.
Finally, the presence of blood-type antigens has been documented on gastric mucins26, but as far as we are 
aware this is the first time that a glycopeptide is presented bearing such a structure.
CONCLUSION
We demonstrated that EThcD with gentle supplemental activation (NCE 15%) may deliver quite 
comprehensive information for O-glycopeptide structure elucidation.  In this process we extended the 
sialoglycan repertoire of urinary glycoproteins. We unambiguously established the presence of a variety of, 
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never reported, mucin-type structures with O-acetyl-sialic acid(s), disialic acids or both. In addition, we also 
identified a trisialo core 1 glycan with O-diacetylsialic acid, and characterized a series of unusual core-2 
structures, including ones displaying a blood-type antigen. 
We observed that the detected glycan oxonium ions were mostly B fragments, and the Y fragments also 
indicated some preference for single bond cleavages. We identified some diagnostic oxonium ions that  may 
not unambiguously prove the presence of certain structures because of the precursor ion interference in such 
complex mixtures, but their absence is determinative.  Larger fragments representing intact penta- and 
hexasaccharides were also detected. We believe these should be more positively considered during scoring.  
These observations should lead to improved automated glycopeptide assignments using EThcD data and the 
resulting methods will provide tools aimed at elucidating this complex yet understudied class of protein 
post-translational modifications.
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 EThcD spectrum of m/z 638.954(3+), identified as 342AVAVT(HexNAcHexNeuAcNeuAcAc)LQSH350 of 
Protein YIPF3. The Gal of the mucin-type core 1 structure is capped with a Neu5,9Ac2 moiety. (This sugar is 
listed as NeuAcAc in the glycan library for database searches). Oxonium and related ions are labeled 
according to the CFG recommendations, for the reducing end fragments – printed in red - the Domon-
Costello nomenclature is followed21. The sialic acid loss from the core GalNAc yields the Y1β fragment. z+1 
peptide ions are distinguished with asterisks. Peptide fragments in blue indicate that some glycan 
fragmentation occurred in EThcD, the loss of the NeuAc and GalNeu5,9Ac2 from the c8 fragment, 
respectively. The asterisk-labeled ion is the charge-reduced form of a doubly charged coeluting molecule. 
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 Part of the EThcD spectra acquired from m/z 760.664(3+) at RT=14.95min (Lower panel) and at 
RT=18.29min (Upper panel). Both spectra were assigned as 
342AVAVT(HexNAc2Hex2NeuAcNeuAcAc)LQSH350 of Protein YIPF3 (for full spectra see Figures S-7 & S-8). 
(NeuAcAc stands for Neu5,9Ac2 in the glycan library for database searches.) However, the glycan fragments 
revealed isomeric glycoforms. The diagnostic fragment ions and the underlying cleavages are indicated in 
matching colors. 
84x61mm (300 x 300 DPI) 
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 EThcD spectrum of m/z 763.992(3+) manually assigned as 342AVAVTLQSH350, modified at Thr-346 with a 
core 1 glycan that features a Neu5,9Ac2 on the Gal residue, and a NeuAc-Neu4,5,9Ac3 disialo-unit on the 
core GalNAc. ‘Pr’ indicates the different forms of the precursor ion. z+1 peptide fragments are distinguished 
with asterisks. The oxonium ions identifying the three different sialic acids are labeled with the CFG symbols, 
for the reducing end fragments – printed in red - the Domon-Costello nomenclature is followed21. The 
GalNAc modifications were considered the β-arm. The asterisk-labeled ion is the charge-reduced form of a 
doubly charged coeluting molecule. 
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 EThcD spectrum of m/z 965.092(3+), identified as 93DVSTPPT(HexNAcHexNeuAc3)VLPDNFPR107 of Insulin-
like growth factor II. The precursor ion and its charge-reduced form are labeled with ‘pr’. The nonreducing 
end fragments are labeled with cartoons according to the CFG recommendations, the reducing end 
fragments, printed in red, follow the nomenclature21. The inset shows the intact glycan and its oxonium ion 
is labeled by a red asterisk. The other asterisk-labeled ion is the charge-reduced form of a doubly charged 
coeluting molecule. For full peaklist see Figure S-10. 
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 EThcD spectrum of m/z 627.634(3+). The database search permitting unspecified modifications identified as 
45VATT(1062.388)VISK52 of Plasma protease C1 inhibitor. z* indicates a z+1 peptide fragment. The intact 
glycan oxonium ion confirms that the peptide is modified by a single oligosaccharide of HexNAc3HexNeuAc 
composition. The glycan fragments helped to decipher the branching and linkages within the 
oligosaccharide, a core 2 based LacdiNAc-like structure22. Scheme 2 illustrates which bonds are cleaved. z* 
indicates a z+1 peptide fragment. The asterisk-labeled ion is the charge-reduced form of a doubly charged 
coeluting molecule. 
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 EThcD spectrum of m/z 944.178 (4+) manually assigned as 345SLTVS*LGPVSKT*EGFPK361 from Protein 
HEG homolog 1 (Q9ULI3), with a core 2 structure carrying a B-antigen on Ser-349 and a sialyl core 3, 
GlcNAc3(NeuAc)GalNAc on Thr-356. The intact sugar oxonium of this glycan was  detected at m/z 
698.266. Its modification site was determined from the series of doubly charged z7-z12 fragments. Scheme 
3 illustrates bond cleavages within the larger glycan structure.The precursor ion and its charge-reduced form 
are labeled with ‘pr’; the charge-reduced form of a coeluting doubly charged component is indicated with an 
asterisk.  Y ions reflect the fragmentation of the core 2 glycan carrying the B antigen. 
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 EThcD spectrum of m/z 766.008(3+) that was manually assigned as 342AVAVTLQSH350 of Protein YIPF3 
bearing a HexNAc3Hex2FucNeuAc glycan on Thr-346. The precursor ion and its charge-reduced form are 
labeled with ‘pr’; the charge-reduced form of a coeluting doubly charged component is indicated with an 
asterisk. The glycan was assigned as a core 2 glycan featuring the A antigen linked to the GalNAc. A similar 
core 2 A antigen has been described on gastric mucin by Rossez et al.26 Scheme 4 illustrates which bonds 
are cleaved. m/z values printed in bold label fragments that indicate fucose transfer between the antennae: 
m/z 803.298 represents a HexNAcHexFucNeuAc structure, while m/z 965.931(2+) was formed via 
HexNAcHex loss from the precursor ion. 
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 Fragmentation of the glycan structure assigned from the spectrum in Figure 3. 
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 Fragmentation of the glycan structure assigned from the spectrum in Figure 5. 
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 Fragmentation of the mucin core 2 glycan carrying blood-type antigen B structure assigned from the 
spectrum in Figure 6. 
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 Fragmentation of the glycan structure assigned from the spectrum in Figure 7. 
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